drug · small molecule
levothyroxine sodium
Phase 2updated 3mo agoby $XERS Xeris Biopharma Holdings, Inc.🔗 ChEMBL
Phase 2community read0 votes
🐶 often sniffed alongside
top 8- drugLevoxyl44 co-mentions · 37 sources
- drugTirosint42 co-mentions · 37 sources
- drugEuthyrox42 co-mentions · 37 sources
- drugErmeza42 co-mentions · 37 sources
- drugLevolet42 co-mentions · 37 sources
- tagRecall40 co-mentions · 37 sources
- companyAccord Healthcare Inc28 co-mentions · 13 sources
- companyMylan Pharmaceuticals Inc19 co-mentions · 19 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 1 investigational indication.
targets
Thyroid hormone receptor
all catalysts(0)
nothing on the calendar yet
Trials studying levothyroxine sodium
- phase4Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH)
- phase2Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism
- phase1Fasting Study of Levothyroxine Sodium Tablets 300 mcg to Synthroid® Tablets 300 mcg
- phase1Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μg
- phase1Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μg
- phase1Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mg
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 24m ago
Found something off?
comments(0)
5-min edit window · permanent after that